Mestag Therapeutics develops precision medicines and antibody therapies that target disease‑driving Sign up to read more
No filings found for this company.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| JOHNSON & JOHNSON INNOVATION - JJDC, INC.CORP | ORDINARY, SERIES SEED PREFERRED | 11,931,706 | 25.2% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 |
Companies with the most similar business descriptions.
Capital raised per employee divides the equity MESTAG THERAPEUTICS LTD raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
A share class is a category of shares carrying its own rights over voting, dividends and what happens to the money if the company is sold or wound up. UK companies typically issue Ordinary shares to founders and employees, then create a new Preferred class at each funding round, giving investors priority on proceeds ahead of the Ordinary holders. MESTAG THERAPEUTICS LTD has 4 distinct classes on file at Companies House; the rights attached to each are reproduced below as filed.
NO VOTING RIGHTS. IN OTHER RESPECTS, RANK PRORATA WITH ORDINARY SHARES, PROVIDED THAT IF ANY GROWTH SHARE IS SUBJECT TO A THRESHOLD AMOUNT, NO SUM SHALL BE PAID ON THAT GROWTH SHARE ON A DISTRIBUTION ON A LIQUIDATION OR SALE, UNTIL AN AMOUNT EQUAL TO THE THRESHOLD AMOUNT HAS BEEN PAID ON EACH SEED SHARE AND ORDINARY SHARE AND THEN ONLY AMOUNTS IN EXCESS OF THAT THRESHOLD AMOUNT SHALL BE PAID.
THE SHARES HAVE ATTACHED TO THEM FULL VOTING, DIVIDEND AND CAPITAL DISTRIBUTION (INCLUDING ON WINDING UP) RIGHTS; THEY DO NOT CONFER ANY RIGHTS OF REDEMPTION.
VOTING RIGHTS - ON A SHOW OF HANDS EACH MEMBER SHALL HAVE ONE VOTE AND ON A POLL EACH MEMBER SHALL HAVE SUCH NUMBER OF VOTES AS EQUALS ONE MULTIPLIED BY THE THEN APPLICABLE CONVERSION RATIO; DIVIDENDS - THE DIVIDENDS OR DISTRIBUTIONS PAYABLE SHALL BE PAID WITH THE INVESTOR CONSENT. A CUMULATIVE FIXED RATE DIVIDEND (THE PREFERRED DIVIDEND) SHALL ACCRUE ON EACH SERIES SEED PREFERRED SHARE AS FROM THE DATE ON WHICH SUCH SHARE WAS FIRST ISSUED UNTIL THE FIRST TO OCCUR OF THE COMPLETION OF A LIQUIDATION EVENT, SALE OR A QUALIFYING IPO (THE DATE OF THE FIRST SUCH EVENT TO OCCUR BEING A PAYMENT DATE). NO PREFERRED DIVIDEND SHALL ACCRUE IN RESPECT OF ANY PERIOD SUBSEQUENT TO A PAYMENT DATE. RETURN OF CAPITAL ON WINDING-UP - THE HOLDERS OF THE SHARE CLASS SHALL BE ENTITLED TO AN AMOUNT PER SERIES SEED PREFERRED SHARE HELD EQUAL TO ANY ARREARS WITH RESPECT TO SUCH SERIES SEED PREFERRED SHARE PROVIDED THAT IF THERE ARE INSUFFICIENT SURPLUS ASSETS TO PAY THE ARREARS IN RESPECT OF ALL OF THE SERIES SEED PREFERRED SHARES, THE REMAINING SURPLUS ASSETS SHALL BE DISTRIBUTED TO THE HOLDERS OF THE SERIES SEED PREFERRED SHARES PRO RATE TO THE ARREARS IN RESPECT OF THE SERIES SEED PREFERRED SHARES RESPECTIVELY HELD BY THEM; AN AMOUNT
These are the directors and secretaries who have left MESTAG THERAPEUTICS LTD. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.
| 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
45 more shareholders on file , sign up free to see.
Some of these officers hold directorships at other companies. Sign up free to see them.
VOTING RIGHTS - ON A SHOW OF HANDS EACH MEMBER SHALL HAVE ONE VOTE AND ON A POLL EACH MEMBER SHALL HAVE SUCH NUMBER OF VOTES AS EQUALS ONE MULTIPLIED BY THE THEN APPLICABLE CONVERSION RATIO; DIVIDENDS - THE DIVIDENDS OR DISTRIBUTIONS PAYABLE SHALL BE PAID WITH THE INVESTOR CONSENT. A CUMULATIVE FIXED RATE DIVIDEND (THE PREFERRED DIVIDEND) SHALL ACCRUE ON